wil506520.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
__________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 28,
2007
AngioDynamics,
Inc.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
000-50761
|
11-3146460
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
603
Queensbury Avenue, Queensbury, New
York 12804
|
(Address
of Principal Executive
Offices) (Zip
Code)
|
|
(518)
798-1215
|
(Registrant’s
telephone number, including area code)
|
Check
the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2 (b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4 (c))
|
Item
8.01. Other
Events.
On
August 28, 2007, AngioDynamics, Inc.
(the “Company”) announced that its Board of Directors elected Mr. Vincent Bucci
as its Chairman. Mr. Bucci joined the Company's Board in January 2007
when the Company acquired RITA Medical Systems, Inc. Mr. Bucci had
been Chairman of the RITA Medical Systems, Inc. board of directors since 2003
and a member of its board since 1994. The size of the Company's
Board of Directors remains unchanged, at nine members. Mr. Bucci succeeds Mr.
Paul Echenberg, who will remain on the Company's Board and continue to serve
on
the Compensation and Nominating and Corporate Governance
committees.
The
Company's August 28, 2007 press release, which is attached hereto as Exhibit
99.1 is incorporated herein by reference.
Item
9.01 – Financial Statements and Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
Press
Release dated August 28, 2007.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
ANGIODYNAMICS,
INC.
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
Date:
August 30, 2007
|
By:
|
D.
Joseph Gersuk
|
|
|
Chief
Financial Officer
|